Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test

Tatjana Radaelli, Kristen Anne Farrell, Larraine Huston-Presley, Saeid Baradaran Amini, John Patrick Kirwan, Harold David McIntyre, Patrick Michael Catalano

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

OBJECTIVE - To determine if glucose and C-peptide values obtained as part of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study could be used to estimate insulin sensitivity during late pregnancy. RESEARCH DESIGN AND METHODS - A total of 78 women enrolled in the HAPO study were recruited for this ancillary study. Venous plasma samples were drawn after an 8- to 10-h fast (time 0) and at 30, 60, 90, and 120 min after a 75-g glucose challenge, which was performed at 24-32 weeks' gestation. Samples were analyzed for plasma glucose, insulin, and C-peptide. Insulin sensitivity was estimated using the established Matsuda and DeFronzo insulin sensitivity index for oral glucose tolerance tests (ISOGTT). Insulin sensitivity was also calculated from two other commonly used indexes of insulin sensitivity (that for homeostasis model assessment [ISHOMA] and that for quantitative insulin sensitivity check index [ISQUICKI]). A new insulin sensitivity index was calculated using the glucose and C-peptide concentrations at 0 and 60 min to derive ISHOMA C-pep, ISQUICKI C-pep, and ISOGTT C-pep. These indexes were then correlated with insulin sensitivity estimated from the ISOGTT. RESULTS - The strongest correlation with the IS OGTT was obtained for ISOGTT C-pep (r = 0.792, PHOMA C-pep and IS QUICKI C-pep with ISOGTT were also significant (r = 0.676, P <0.001 and r = 0.707, P <0.001, respectively). CONCLUSIONS - These data suggest that calculated ISOGTT C-pep is an excellent predictor of insulin sensitivity in pregnancy and can be used to estimate insulin sensitivity in over 25,000 women participating in the HAPO study.

Original languageEnglish
Pages (from-to)490-494
Number of pages5
JournalDiabetes Care
Volume33
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

C-Peptide
Pregnancy Outcome
Glucose Tolerance Test
Hyperglycemia
Insulin Resistance
Glucose
Outcome Assessment (Health Care)
Pregnancy
Homeostasis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialised Nursing

Cite this

Radaelli, T., Farrell, K. A., Huston-Presley, L., Amini, S. B., Kirwan, J. P., McIntyre, H. D., & Catalano, P. M. (2010). Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. Diabetes Care, 33(3), 490-494. https://doi.org/10.2337/dc09-1463

Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. / Radaelli, Tatjana; Farrell, Kristen Anne; Huston-Presley, Larraine; Amini, Saeid Baradaran; Kirwan, John Patrick; McIntyre, Harold David; Catalano, Patrick Michael.

In: Diabetes Care, Vol. 33, No. 3, 03.2010, p. 490-494.

Research output: Contribution to journalArticle

Radaelli, Tatjana ; Farrell, Kristen Anne ; Huston-Presley, Larraine ; Amini, Saeid Baradaran ; Kirwan, John Patrick ; McIntyre, Harold David ; Catalano, Patrick Michael. / Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. In: Diabetes Care. 2010 ; Vol. 33, No. 3. pp. 490-494.
@article{e61e8c38db5c4748ba83f9498430a8a4,
title = "Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test",
abstract = "OBJECTIVE - To determine if glucose and C-peptide values obtained as part of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study could be used to estimate insulin sensitivity during late pregnancy. RESEARCH DESIGN AND METHODS - A total of 78 women enrolled in the HAPO study were recruited for this ancillary study. Venous plasma samples were drawn after an 8- to 10-h fast (time 0) and at 30, 60, 90, and 120 min after a 75-g glucose challenge, which was performed at 24-32 weeks' gestation. Samples were analyzed for plasma glucose, insulin, and C-peptide. Insulin sensitivity was estimated using the established Matsuda and DeFronzo insulin sensitivity index for oral glucose tolerance tests (ISOGTT). Insulin sensitivity was also calculated from two other commonly used indexes of insulin sensitivity (that for homeostasis model assessment [ISHOMA] and that for quantitative insulin sensitivity check index [ISQUICKI]). A new insulin sensitivity index was calculated using the glucose and C-peptide concentrations at 0 and 60 min to derive ISHOMA C-pep, ISQUICKI C-pep, and ISOGTT C-pep. These indexes were then correlated with insulin sensitivity estimated from the ISOGTT. RESULTS - The strongest correlation with the IS OGTT was obtained for ISOGTT C-pep (r = 0.792, PHOMA C-pep and IS QUICKI C-pep with ISOGTT were also significant (r = 0.676, P <0.001 and r = 0.707, P <0.001, respectively). CONCLUSIONS - These data suggest that calculated ISOGTT C-pep is an excellent predictor of insulin sensitivity in pregnancy and can be used to estimate insulin sensitivity in over 25,000 women participating in the HAPO study.",
author = "Tatjana Radaelli and Farrell, {Kristen Anne} and Larraine Huston-Presley and Amini, {Saeid Baradaran} and Kirwan, {John Patrick} and McIntyre, {Harold David} and Catalano, {Patrick Michael}",
year = "2010",
month = "3",
doi = "10.2337/dc09-1463",
language = "English",
volume = "33",
pages = "490--494",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test

AU - Radaelli, Tatjana

AU - Farrell, Kristen Anne

AU - Huston-Presley, Larraine

AU - Amini, Saeid Baradaran

AU - Kirwan, John Patrick

AU - McIntyre, Harold David

AU - Catalano, Patrick Michael

PY - 2010/3

Y1 - 2010/3

N2 - OBJECTIVE - To determine if glucose and C-peptide values obtained as part of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study could be used to estimate insulin sensitivity during late pregnancy. RESEARCH DESIGN AND METHODS - A total of 78 women enrolled in the HAPO study were recruited for this ancillary study. Venous plasma samples were drawn after an 8- to 10-h fast (time 0) and at 30, 60, 90, and 120 min after a 75-g glucose challenge, which was performed at 24-32 weeks' gestation. Samples were analyzed for plasma glucose, insulin, and C-peptide. Insulin sensitivity was estimated using the established Matsuda and DeFronzo insulin sensitivity index for oral glucose tolerance tests (ISOGTT). Insulin sensitivity was also calculated from two other commonly used indexes of insulin sensitivity (that for homeostasis model assessment [ISHOMA] and that for quantitative insulin sensitivity check index [ISQUICKI]). A new insulin sensitivity index was calculated using the glucose and C-peptide concentrations at 0 and 60 min to derive ISHOMA C-pep, ISQUICKI C-pep, and ISOGTT C-pep. These indexes were then correlated with insulin sensitivity estimated from the ISOGTT. RESULTS - The strongest correlation with the IS OGTT was obtained for ISOGTT C-pep (r = 0.792, PHOMA C-pep and IS QUICKI C-pep with ISOGTT were also significant (r = 0.676, P <0.001 and r = 0.707, P <0.001, respectively). CONCLUSIONS - These data suggest that calculated ISOGTT C-pep is an excellent predictor of insulin sensitivity in pregnancy and can be used to estimate insulin sensitivity in over 25,000 women participating in the HAPO study.

AB - OBJECTIVE - To determine if glucose and C-peptide values obtained as part of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study could be used to estimate insulin sensitivity during late pregnancy. RESEARCH DESIGN AND METHODS - A total of 78 women enrolled in the HAPO study were recruited for this ancillary study. Venous plasma samples were drawn after an 8- to 10-h fast (time 0) and at 30, 60, 90, and 120 min after a 75-g glucose challenge, which was performed at 24-32 weeks' gestation. Samples were analyzed for plasma glucose, insulin, and C-peptide. Insulin sensitivity was estimated using the established Matsuda and DeFronzo insulin sensitivity index for oral glucose tolerance tests (ISOGTT). Insulin sensitivity was also calculated from two other commonly used indexes of insulin sensitivity (that for homeostasis model assessment [ISHOMA] and that for quantitative insulin sensitivity check index [ISQUICKI]). A new insulin sensitivity index was calculated using the glucose and C-peptide concentrations at 0 and 60 min to derive ISHOMA C-pep, ISQUICKI C-pep, and ISOGTT C-pep. These indexes were then correlated with insulin sensitivity estimated from the ISOGTT. RESULTS - The strongest correlation with the IS OGTT was obtained for ISOGTT C-pep (r = 0.792, PHOMA C-pep and IS QUICKI C-pep with ISOGTT were also significant (r = 0.676, P <0.001 and r = 0.707, P <0.001, respectively). CONCLUSIONS - These data suggest that calculated ISOGTT C-pep is an excellent predictor of insulin sensitivity in pregnancy and can be used to estimate insulin sensitivity in over 25,000 women participating in the HAPO study.

UR - http://www.scopus.com/inward/record.url?scp=77649252159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649252159&partnerID=8YFLogxK

U2 - 10.2337/dc09-1463

DO - 10.2337/dc09-1463

M3 - Article

C2 - 20032280

AN - SCOPUS:77649252159

VL - 33

SP - 490

EP - 494

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 3

ER -